Corvex Management LP is Director & 10% Owner at GeneDx Holdings Corp. (WGS). They have made 5 open-market trades across 2 companies since 2024, most recently 2025-12-17.
CIK 0001535472
5 open-market purchases totalling $23.4M since 2024, never a sale. Across 5 scored buys the stock is up 22.5% at ninety days, and 17.5 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| EGN | 9,710,474 | $700.3M |
| VSTS | 19,604,121 | $272.4M |
| WGS | 3,033,985 | $193.4M |
| Total | $1.2B |
Shares reported on the most recent Form 4, priced at the 2025-12-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 20% | 100% |
| Avg Move | +0.3% | -2.5% | +22.5% |
| Alpha | -0.4% | -5.1% | +17.5% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VSTS | BUY | 2025-12-16 | 2025-12-17 | $6.81 | $13.7M | -6.2% | -4.7% | +6.0% |
| WGS | BUY | 2025-05-14 | 2025-05-16 | $60.16 | $6.0M | +3.2% | -1.4% | +81.2% |
| VSTS | BUY | 2024-05-24 | 2024-05-24 | $12.02 | $1.2M | +2.9% | +0.2% | +9.3% |
| VSTS | BUY | 2024-05-23 | 2024-05-23 | $12.17 | $1.2M | +1.7% | -1.6% | +9.2% |
| VSTS | BUY | 2024-05-21 | 2024-05-21 | $12.50 | $1.3M | -0.1% | -5.0% | +6.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.